Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Iron Overload in Beta-Thalassemia Major
NCT05777733Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Mar 2024
- Primary completion
- Apr 2024
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of acetylcysteine in beta thalassemia, sponsored by Assiut University. Primary endpoint: Serum ferritin level at 6 months. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT05777733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05777733.